Covid-19 In China: China issues new Covid control protocol, emphasis on monitoring mutated variants

Posted on 9th Jan 2023 by rohit kumar

Because of the increasing cases of coronavirus in China, the Joint Prevention and Control Mechanism of the State Council of the country released the 10th edition of the Virus Control Protocol on Saturday. The new plan emphasizes the protection of key groups by monitoring and early warning of mutated variants as well as preventing severe cases.

 

talk of promoting vaccination

This new edition is issued following the decision to downgrade Epidemic Management from Class A to Class B. Along with this, it calls for increasing vaccination and self-protection. This 10th edition also emphasizes increased surveillance of new variants and the use of the National Influenza Surveillance Network. And according to the National Influenza Surveillance Network, 554 national influenzas monitor sentinel hospitals are required for influenza-like illness (ILI) and severe acute respiratory infection (SARI) surveillance.

 

Information about new cases of corona will have to be given within 24 hours

It has been told in the new plan that to trace the virus mutation, there will be a need to collect samples of outpatients, emergency and serious cases, and deaths in hospitals. At the same time, information about its results will have to be given to the Institute of Virology of the Chinese Center for Disease Control and Prevention. In addition, medical institutions must submit reports of new corona cases within 24 hours to the Direct Online Reporting System operated by the China CDC. As per the earlier protocol, these cases were required to be reported within two hours.

 

Talk of promoting vaccination among the elderly

The new plan suggests timely epidemiological investigations to disease control departments. At the same time, the new version also calls for promoting vaccination among the elderly. Who should ideally get two doses of the vaccine and booster shots?

 

Also Read: Covid-19 In China: New wave of the corona is not stopping in China, trial production of mRNA vaccine started

Other news